Covington Guides Illumina In $350M Buy Of Verinata
California-based Illumina Inc. has agreed to pick up chromosome testing company Verinata Health Inc. for at least $350 million to grow its intellectual property portfolio for noninvasive prenatal testing, Illumina announced...To view the full article, register now.
Already a subscriber? Click here to view full article